![Carl Kraus](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carl Kraus
Direttore Tecnico/Scientifico/R&S presso
i3 Research, Inc.
Patrimonio netto: 1 M $ in data 30/06/2026
Profilo
Carl N.
Kraus was the founder of Arrevus, Inc., founded in 2015, where the titles held included Chairman, President & Chief Executive Officer from 2017 to 2021.
The current job is Medical Director at i3 Research, Inc. Former jobs include Chief Medical Officer at Idera Pharmaceuticals, Inc., Chief Medical Officer at Resilience Government Services, Inc., Chief Medical Officer at Aceragen, Inc. from 2021 to 2023, and Chief Medical Officer at Aquestive Therapeutics, Inc. from 2023 to 2025.
Education includes undergraduate studies at Washington University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/10/2025 | 282.475 ( 0,23% ) | 1 M $ | 30/06/2026 |
Posizioni attive di Carl Kraus
| Società | Posizione | Inizio |
|---|---|---|
i3 Research, Inc.
 i3 Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts oncology, central nervous system, and respiratory research | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Carl Kraus
| Società | Posizione | Fine |
|---|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 04/11/2025 |
| ACERAGEN, INC. | Direttore Tecnico/Scientifico/R&S | 30/04/2023 |
Arrevus, Inc.
 Arrevus, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies for orphan infectious diseases | Amministratore Delegato | 31/10/2021 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Direttore Tecnico/Scientifico/R&S | - |
Resilience Government Services, Inc.
 Resilience Government Services, Inc. Pharmaceuticals: MajorHealth Technology Operates as an integrated biopharmaceutical company | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Carl Kraus
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
14
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Aquestive Therapeutics, Inc.
 Aquestive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes thin film pharmaceutical and over the counter drug products | Health Technology |
i3 Research, Inc.
i3 Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts oncology, central nervous system, and respiratory research | Commercial Services |
Resilience Government Services, Inc.
Resilience Government Services, Inc. Pharmaceuticals: MajorHealth Technology Operates as an integrated biopharmaceutical company | Health Technology |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arrevus, Inc.
Arrevus, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies for orphan infectious diseases | Health Technology |
Aceragen, Inc.
 Aceragen, Inc. BiotechnologyHealth Technology Discovers, develops, and commercializes therapeutics for oncology and rare diseases | Health Technology |
